Guangzhou Kaipu Biotechnology Co., Ltd. is a limited liability company (Taiwan, Hong Kong, Macao and domestic joint venture) incorporated in Huangpu District, Guangzhou City, Guangdong Province, Guangdong Province, with a registered address at No. 71, Fenghuang San Heng Road, Sino-Singapore Guangzhou Knowledge City, Guangzhou, China.
Guangzhou Kaipu Biotechnology Co., Ltd.'s unified social credit code/registration number is 914401165915471894, the enterprise's legal person is Qiaozhong Guan, and the enterprise is currently in the state of opening.
Guangzhou Kaipu Biotechnology Co., Ltd. business scope is: biotechnology technology transfer services; biotechnology consulting, exchange services; biotechnology development services; biomedical technology research; non-licensed medical device business; medical equipment leasing services; office equipment leasing services; medical research and experimental development; pharmaceutical research and development; biotechnology promotion services; human scientific research results transfer services ; chemical engineering research services; computer applications electronic equipment manufacturing; computer information security equipment manufacturing; computer network systems engineering services; computer technology development, technical services; housing rental; site rental (excluding warehousing); licensed medical device business; medical diagnostic, monitoring and therapeutic equipment wholesale; chemical pharmaceutical preparations, biological products (including vaccines) wholesale;. In Guangdong Province, the total registered capital of companies with similar business scope is 25,159,770,000 yuan, and the main capital is concentrated in 10-50 million and 1-10 million size of the enterprise, ***6686. Within this province, the current registered capital of enterprises is excellent.
Guangzhou Kaipu Biotechnology Co., Ltd. has invested in 8 companies externally and has 0 branches.
View more information and information about Guangzhou Kaipu Biotechnology Co. through Baidu Enterprise Credit.